Jingjing Xu
First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Inflammasome and immune disorders, NF-κB Signaling Pathways, Inflammation biomarkers and pathways, Pain Mechanisms and Treatments, Spine and Intervertebral Disc Pathology
Most-Cited Works
- → Lactate Suppresses Macrophage Pro-Inflammatory Response to LPS Stimulation by Inhibition of YAP and NF-κB Activation via GPR81-Mediated Signaling(2020)247 cited
- → MiR‐30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B‐cell lymphoma(2017)55 cited
- → CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin(2018)53 cited
- → The ubiquitin ligase CHIP modulates cellular behaviors of gastric cancer cells by regulating TRAF2(2019)20 cited
- → Machine Learning Screening and Validation of PANoptosis-Related Gene Signatures in Sepsis(2024)13 cited
- → Successful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-κB activity(2011)12 cited
- → microRNA‐125b‐5p alleviated CCI‐induced neuropathic pain and modulated neuroinflammation via targeting SOX11(2024)10 cited
- → Nuclear CD24 promotes IL-6 secretion in fibroblasts(2025)1 cited